VTCN1 and cancer: Similarly, Chen et al. [16] also reported that B7-H1, B7-H3, and B7-H4 molecules are involved in pancreatic cancer progression, and indicated that their co-expression could be used as a valuable prognostic marker, and can have important clinical application in predicting cancer patients' prognosis.